Have a personal or library account? Click to login

Figures & Tables

Figure 1

Results of single-step in-house PCR and nested-PCR. Lane 1: Negative control; lane 2: ATCC BA847 H. cinaedi positive control; lane 3-8: positive samples for H. cinaedi DNA, ~359 bp; lane 9: Size marker 100 bp ladder
Results of single-step in-house PCR and nested-PCR. Lane 1: Negative control; lane 2: ATCC BA847 H. cinaedi positive control; lane 3-8: positive samples for H. cinaedi DNA, ~359 bp; lane 9: Size marker 100 bp ladder

The demographical characteristics of the patient and control groups

VariablesPatient Group (n: 129)Control Group (n: 146)p
Age (mean ± SD)61.24 ± 8.34563.55 ± 7.92>0.05
F35 (27.1%)36 (24.7%)>0.05
Gender
M94 (72.9%)110 (75.3%)>0.05
Yes50 (38.8%)53 (36.3%)>0.05
Smoking
No79 (61.2%)93 (63.7%)>0.05
Total Cholesterol (mg/dL)194.63 ± 53.71220.54 ± 470.0001
Triglyceride (mg/dL)142.38 ± 106.59148.29 ± 110.030.651
High-density lipoprotein (mg/dL)51.06 ± 17.4447.95 ± 18.160.149
Low-density lipoprotein (mg/dL)112.14 ± 40.24130.23 ± 42.050.0001
Fasting blood sugar (mg/dL)107.49 ± 23.49107.74 ± 27.090.936
H. cinaedi6 (4.65%)0 (0%)0.010

Results of logistic regressions according to the variables in the patient group

BS.E.WalddfSig.OR95% C.I.
LowerUpper
Age0.0410.0175.75310.0161.0421.0081.078
Gender (male)0.0010.1530.00010.9971.0010.7421.349
Total (≥200 Cholesterol mg/dL)0.6150.15116.47010.0001.8491.3742.488
(≥Triglyceride 150 mg/dL)0.0710.1470.23010.6321.0730.8041.432
High-density (≥50 mg/lipoprotein dL)-0.2950.1434.27310.0390.7450.5630.985
Low-density (≥100 mg/lipoprotein dL)0.1930.1651.37110.2421.2130.8781.676
Fasting (≥125 Blood mg/dL) Sugar-0.1600.1760.83110.3620.8520.6041.202
H. cinaedi presence10.7697720.800.00010.999475270.000
Constant7.8247720.800.00010.9992499.6

Comparison of patient and control groups for various variables

VariablesPatient GroupControl Groupχ2pOR%95 CI
MinMax
Smoking50530.1770.6741.110.6811.811
Total* (≥200 Cholesterol mg/dL)966426.320.0013.7272.2316.226
Triglyceride* (≥150 mg/dL)41220.2960.5871.1540.6891.932
High-density* (≥50 mg/lipoprotein dL)801032.2400.1350.6820.4121.127
Low-density* (≥100 mg/lipoprotein dL)102928.4970.0042.2171.2913.809
Fasting (≥125 blood* mg/dL) sugar20290.8890.3460.7400.3961.385
H. cinaedi presence**60-0.010-0.4010.521

Primers used in the nested-PCR method [5]

Sequences (5’-3’)Product size
H.cinaedi1F: GGA GCT GTG AGT GTG CTG 1R: AAA TGA CCG ACA CGA GCT G659 bp
H. cinaedi (nested PCR)2F: GGA TTT AGG CTC TCG CTC TCG TCC GGA TAT 2R: ATC GCC GTC CTT ACT CGC GTC TCC AA ATTA359 bp
Beta-globinF: ACA CAA CTG TGT TCA CTA GC R: GGA AAA TAG ACC AAT AGG CTG251 bp
Language: English
Page range: 529 - 536
Submitted on: Mar 18, 2020
Accepted on: Dec 8, 2020
Published on: Oct 21, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2021 Tevhide Ziver Sarp, Safa Gode, Suat Saribas, Sevgi Ergin, Gökhan Kasnak, Harika Oyku Dinc, Halit Tokman, Banu Tufan Kocak, Melike Keskin, Hrisi Bahar Tokman, Bekir Kocazeybek, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.